Abstract:In the light of the steady increase of infections related to vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA), the medicinal plant Magnolia officinalis was subjected to bioassay-directed fractionation, which led to the isolation of the known neolignans piperitylmagnolol (1), magnolol (2), and honokiol (3) from the MeOH extract. In broth-microdilution assays, 1-3 exhibited antibacterial activities against VRE and MRSA at minimum-inhibitory concentrations (MIC) in the range of 6.25-25 microg/ml, compound 1 being the most-potent antibiotic. The ratio of MBC/MIC (MBC = minimum bactericidal concentration) was < or = 2 for all compounds. The kinetics of the antibacterial action of 1 and 3 were studied by means of time-kill assays; both compounds were bactericidal against VRE and MRSA, their actions being time dependent, or both time and concentration dependent. Magnolol (2) was acetylated to magnolol monoacetate (4) and magnolol diacetate (5) (partial or full masking of the phenolic OH functions). The cytotoxic properties of 1-5 against human OVCAR-3 (ovarian adenocarcinoma), HepG2 (hepatocellular carcinoma), and HeLa (cervical epitheloid carcinoma) cell lines were evaluated. The CD50 values for compounds 1-3 were in the range of 3.3-13.3 microg/ml, derivatives 4 and 5 being much less potent. This study indicates that piperitylmagnolol (= 3-[(1S,6S)-6-isopropyl-3-methylcyclohex-2-enyl]-5,5'-di(prop-2-enyl)[1,1'-biphenyl]-2,2'-diol; 1) possesses both significant anti-VRE activity and moderate cytotoxicity against the above cancer cell lines.

Cytotoxic Lignans from the Stem Bark of Magnolia Officinalis

Two New Lignans from the Stem Bark of Magnolia Obovata and Their Cytotoxic Activity

A Cytotoxic Monoterpene-Neolignan from the Stem Bark of Magnolia Officinalis

ChemInform Abstract: Two New Lignans from the Stem Bark of Magnolia Obovata and Their Cytotoxic Activity

Biphenyl-type neolignans from stem bark of Magnolia officinalis with potential anti-tumor activity

Apoptosis-inducing and antitumor activity of neolignans isolated from Magnolia officinalis in HeLa cancer cells.

Antibacterial Constituents from Magnolia officinalis

Three rare anti-inflammatory sesquiterpene lactones from Magnolia grandiflora

Two New Neolignans from Manglietia Insignis

Chemical Constituents from the Leaves and Twigs of Magnolia Decidua

New Oligomeric Neolignans from the Leaves of Magnolia Officinalis Var. Biloba

Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis

Bioactive Phenolics and Terpenoids from Manglietia Insignis.

Anti-inflammatory Neolignans from the Roots of Magnolia Officinalis.

Discovery of diverse sesquiterpenoids from Magnolia grandiflora with cytotoxic activities by inducing cell apoptosis

Four New Honokiol Derivatives from the Stem Bark of Magnolia Officinalis and Their Anticholinesterase Activities

Anti-inflammatory Lignans from Melodinus Suaveolens

Alkaloids and lignans with acetylcholinesterase inhibitory activity from the flower buds of<i>Magnolia biondii</i>Pamp

Comparative Anti-Cancer and Anti-Inflammatory Activities of Essential Oils from the Bark and Flower of Magnolia officinalis Rehd. et Wils

Lignans from bark of Larix olgensis var. koreana.

Lignans from the stem bark of Syringa pinnatifolia.